M. Schiebe et al., 13-CIS RETINOIC ACID, INTERFERON-ALPHA AND CONCOMITANT IRRADIATION INA PATIENT WITH NON-SMALL-CELL LUNG-CANCER - DESCRIPTION OF TOXICITY AND RESPONSE, Onkologie, 19(6), 1996, pp. 508-511
Background: Interferon-alpha (IFN-alpha) and retinoic acid have been f
ound to be active agents in the treatment of squamous-cell carcinomas.
Recent experimental and clinical studies indicate an improvement of t
reatment results, if this agents are combined with irradiation. Materi
al and Method: We report about a 53-year-old patient presenting with a
n advanced non-small-cell lung cancer. Systemical treatment with IFN-a
lpha and 13-cis retinoic acid was performed concurrently with radiothe
rapy. The patient's follow-up, response and toxicity of this therapeut
ic regimen were evaluated. Result and Conclusions: The combination of
IFN-alpha/retinoic acid with irradiation seems to be effective in the
management of advanced non-small-cell carcinomas of the lung. However,
in rare cases combined treatment with IFN-alpha and radiotherapy may
be associated with increased side effects, especially radiation pneumo
nitis.